• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将绝对吞噬细胞计数与绝对中性粒细胞计数相结合,作为儿科肿瘤发热性中性粒细胞减少症安全出院的衡量标准:一项试点研究。

Incorporating Absolute Phagocyte Count With Absolute Neutrophil Count as a Measure for Safe Discharge for Pediatric Oncology Febrile Neutropenia: A Pilot Study.

机构信息

Department of Pediatrics, Division of General Pediatrics.

Department of Public Health Sciences, Hollings Cancer Center & South Carolina Clinical and Translational Research Institute, Medical University of South Carolina, Charleston, SC.

出版信息

J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e1000-e1002. doi: 10.1097/MPH.0000000000001974.

DOI:10.1097/MPH.0000000000001974
PMID:33065712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8046833/
Abstract

Adequate bone marrow recovery is a discharge requirement after admission for febrile neutropenia in oncology patients, without specific threshold in consensus guidelines. In January 2016, our institution implemented count recovery criteria of absolute neutrophil count ≥100 cells/μL and absolute phagocyte count ≥300 cells/μL compared with prior criteria of absolute neutrophil count ≥500 cells/μL. Retrospective analysis comparing pre (July 2013 to December 2015, N=68) and post (January 2016 to June 2018, N=30) groups showed no difference in readmissions (P>0.9), no patient deaths, and decreased average length of stay in the post group (P<0.0001). Updated count recovery criteria seem feasible and safe.

摘要

充分的骨髓恢复是肿瘤患者因发热性中性粒细胞减少症入院后的出院要求,共识指南中没有具体的阈值。2016 年 1 月,我院实施了绝对中性粒细胞计数≥100 个/μL 和绝对吞噬细胞计数≥300 个/μL 的计数恢复标准,而之前的标准为绝对中性粒细胞计数≥500 个/μL。回顾性分析比较了前(2013 年 7 月至 2015 年 12 月,N=68)和后(2016 年 1 月至 2018 年 6 月,N=30)两组,结果显示再入院率(P>0.9)、无患者死亡以及在后组中平均住院时间缩短(P<0.0001)没有差异。更新的计数恢复标准似乎是可行和安全的。

相似文献

1
Incorporating Absolute Phagocyte Count With Absolute Neutrophil Count as a Measure for Safe Discharge for Pediatric Oncology Febrile Neutropenia: A Pilot Study.将绝对吞噬细胞计数与绝对中性粒细胞计数相结合,作为儿科肿瘤发热性中性粒细胞减少症安全出院的衡量标准:一项试点研究。
J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e1000-e1002. doi: 10.1097/MPH.0000000000001974.
2
Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.使用绝对中性粒细胞计数阈值作为骨髓充分恢复的替代标志物,评估癌症合并发热性中性粒细胞减少症患儿停用抗生素后出院的安全性。
Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26875. Epub 2017 Nov 8.
3
Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.因发热住院的中性粒细胞减少患者骨髓恢复的血液学预测指标:对停用抗生素及早期出院的意义
J Pediatr. 1992 Jul;121(1):28-33. doi: 10.1016/s0022-3476(05)82536-3.
4
Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.绝对单核细胞计数作为儿科肿瘤患者无病因发热性中性粒细胞减少症中早期、安全的抗生素停药标志物。
J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e702-e709. doi: 10.1097/MPH.0000000000002696. Epub 2023 Jun 26.
5
Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia.评估因发热性中性粒细胞减少症而住院的儿科肿瘤患者的安全出院标准。
J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e880-e885. doi: 10.1097/MPH.0000000000002074.
6
Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.发热性中性粒细胞减少症入院后绝对中性粒细胞计数恢复前出院患儿的结局。
J Pediatr Hematol Oncol. 2023 Nov 1;45(8):e948-e952. doi: 10.1097/MPH.0000000000002757. Epub 2023 Sep 13.
7
Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia.部分患有癌症且中性粒细胞减少持续时间较长的发热儿童及青少年早期出院的安全性
Med Pediatr Oncol. 1997 Mar;28(3):191-5. doi: 10.1002/(sici)1096-911x(199703)28:3<191::aid-mpo7>3.0.co;2-e.
8
Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.美罗培南与哌拉西林-他唑巴坦作为儿科肿瘤患者发热性中性粒细胞减少症的经验性治疗药物
Asian Pac J Cancer Prev. 2014;15(11):4549-53. doi: 10.7314/apjcp.2014.15.11.4549.
9
FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.埃塞俄比亚亚的斯亚贝巴提库兰贝萨专科医院收治的发热性中性粒细胞减少症儿科癌症患者治疗结果的相关因素。
Ethiop Med J. 2017 Jan;55(1):43-7.
10
Pediatric Oncology Discharges With Febrile Neutropenia: Variation in Location of Care.
J Pediatr Hematol Oncol. 2017 Jan;39(1):e1-e7. doi: 10.1097/MPH.0000000000000716.

引用本文的文献

1
A Method for Expanding the Training Set of White Blood Cell Images.一种扩充白细胞图像数据集的方法。
J Healthc Eng. 2022 Nov 9;2022:1267080. doi: 10.1155/2022/1267080. eCollection 2022.